Press release
Geriatric Medicines Market Huge Demand & Future Scope Including Top Players - GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc
Geriatric medicines, also called geriatrics is a division of medicines associated with preventive, clinical, remedial, and social aspects of disease generally amongst people that are aged over 65 years or more. In response to the needs of an aging population, demand for geriatric medicines and appropriate cure has developed rapidly during last decades. The proper medical care for the geriatric patients across the range of ill health conditions includes co-morbid complications such as syncope, cerebral aging, and falls among others.
Request for free sample copy of this report @ https://www.polarismarketresearch.com/industry-analysis/geriatric-medicines-market/request-for-free-sample
The global geriatric medicines market is majorly driven by the factor including a rise in geriatric populations. According to the Eurostat, the number of people aged 65 years and above is expected reach 141 million by 2050 globally. In addition, the high market growth is expected on account of the increasing occurrence of numerous target disorders in the geriatric population, the demographic modification, the rising trend in lifestyle-associated risk aspects, and the considerably developed access to economic medicine across the developing and emerging regions.
Continuous R&D activities commenced by key players and pharmaceutical companies to provide to the patient demand is expected to gain the significant outcomes during the forecast period. Increasing occurrence of chronic ailments, refining healthcare organization in emerging economies, increasing acceptance of medical tourism, government initiatives as well as support to provide timely care, and increasing number of specialty clinics are some of the other factors driving of the geriatric medicines market. However, difficulties associated with drug compatibility, lack of patient involvement in clinical trials, and side effects associated with the medications are the factors hampering the market growth.
Make an inquiry for purchasing this report @ https://www.polarismarketresearch.com/industry-analysis/geriatric-medicines-market/inquire-before-buying
North America is estimated to dominate the global Geriatric Medicines Market. The existence of developed healthcare facilities, favorable reimbursement policies, and the easy availability of important as well as life-saving medicine has significantly enhanced the average life expectancy rates in North America. Moreover, the number of people that are over 65 to 70 years suffering several target ailments is increasing continually which is further anticipated to boost the geriatric medicines market during the forecast period.
Some major key players in global Geriatric Medicines Market include GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc, Merck & Company Inc., and Sanofi S.A. among others.
Browse Complete Summary of this report @ https://www.polarismarketresearch.com/industry-analysis/geriatric-medicines-market/
About us Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.
We mainly focus on aiding our customers with substantial competitive intelligence, helping them to secure a competitive advantage in the market and accomplish sustainable growth in different market domains. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. Through dedicated qualitative and quantitative primary and secondary market research and consulting assignments, we adeptly formulate competitive strategies to address business challenges for our clients through analyzing market trends and emerging technologies.
Contact us-
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Geriatric Medicines Market Huge Demand & Future Scope Including Top Players - GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc here
News-ID: 1295787 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Cell Dissociation Market Set to Surge to USD 1,161.06 Million by 2032, with Annu โฆ
๐๐๐๐จ๐ซ๐๐ข๐ง๐ ๐ญ๐จ ๐ญ๐ก๐ ๐ซ๐๐ฌ๐๐๐ซ๐๐ก ๐ซ๐๐ฉ๐จ๐ซ๐ญ, ๐ญ๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐๐๐ฅ๐ฅ ๐๐ข๐ฌ๐ฌ๐จ๐๐ข๐๐ญ๐ข๐จ๐ง ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐ฏ๐๐ฅ๐ฎ๐๐ ๐๐ญ ๐๐๐ ๐๐๐.๐๐ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐๐ง๐ ๐ข๐ฌ ๐๐ฑ๐ฉ๐๐๐ญ๐๐ ๐ญ๐จ ๐ซ๐๐๐๐ก ๐๐๐ ๐,๐๐๐.๐๐ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐๐ญ ๐ ๐๐๐๐ ๐จ๐ ๐๐.๐% ๐๐ฎ๐ซ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐จ๐ซ๐๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐ข๐จ๐.
Technological progressions, growing demand for cell-dependent assays and remedies, growing funding in research and development, and escalating approval of regenerative medicines are prominent trends shaping the industry's future. Our thorough analysis ofโฆ
Surface Mount Technology Market Share Reach USD 10.00 Billion by 2032 | Growing โฆ
๐๐ก๐ ๐ฅ๐๐ญ๐๐ฌ๐ญ ๐ซ๐๐ฌ๐๐๐ซ๐๐ก ๐ฌ๐ญ๐ฎ๐๐ฒ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐ซ๐๐ฏ๐๐๐ฅ๐ฌ ๐ญ๐ก๐๐ญ ๐ญ๐ก๐ ๐๐ฎ๐ซ๐๐๐๐ ๐๐จ๐ฎ๐ง๐ญ ๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐ฉ๐จ๐ข๐ฌ๐๐ ๐ญ๐จ ๐ฐ๐ข๐ญ๐ง๐๐ฌ๐ฌ ๐ ๐ฌ๐ญ๐๐๐๐ฒ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐ ๐๐ง๐ง๐ฎ๐๐ฅ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ซ๐๐ญ๐ (๐๐๐๐) ๐จ๐ 8.30% ๐จ๐ฏ๐๐ซ ๐ญ๐ก๐ ๐๐จ๐ซ๐๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐ข๐จ๐ ๐๐ซ๐จ๐ฆ 2024 ๐ญ๐จ 2032. ๐๐ก๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐ฏ๐๐ฅ๐ฎ๐๐ ๐๐ญ ๐๐๐ 4.88 ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง 2023 ๐๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐จ๐ฃ๐๐๐ญ๐๐ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐ญ๐จ ๐๐๐ 10.00 ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ 2032. The growing trend of miniaturization in the electronics sector has led to increasedโฆ
Fitness Equipment Market size is expected to reach US$ 26.31 Billion by 2032, at โฆ
๐ป๐๐ ๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐ ๐๐๐๐ ๐๐๐ ๐๐๐๐๐ ๐๐๐๐๐
๐๐ ๐๐ ๐๐๐๐๐๐ ๐๐๐๐๐. ๐ฐ๐ ๐๐๐๐ ๐๐๐๐ ๐๐๐๐ ๐ผ๐บ๐ซ 16.76 ๐๐๐๐๐๐๐ ๐๐ 2023 ๐๐ ๐ผ๐บ๐ซ 26.31 ๐๐๐๐๐๐๐ ๐๐ 2032 ๐๐ ๐ ๐๐๐๐๐๐๐๐
๐๐๐๐๐๐ ๐๐๐๐๐๐ ๐๐๐๐ (๐ช๐จ๐ฎ๐น) ๐๐ 5.2% ๐
๐๐๐๐๐ ๐๐๐ ๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐
. ๐ป๐๐ ๐๐๐
๐๐๐๐๐ ๐๐๐ ๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐ ๐๐๐ ๐๐๐๐๐, ๐๐๐๐๐๐ ๐
๐๐ ๐๐ ๐๐๐๐๐๐ ๐
๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐, ๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐๐๐๐๐๐๐ ๐๐ ๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐ ๐๐๐ ๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐, ๐๐๐
๐ ๐๐๐๐๐โฆ
Impregnating Resins Market Envisioned to Attain US$ 3.30 Billion by 2032, Growin โฆ
The growing demand for impregnating resins for the electrical industry to improve the lifespan of industrial machinery is a major trend shaping the industry's future. Our thorough analysis of the Impregnating Resins Market covers the industry size, share, recent developments, and top trends. Besides, an in-depth examination of all the major regions and segments has been covered.
๐๐ข๐ฌ๐๐จ๐ฏ๐๐ซ ๐๐ฎ๐ซ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐ฐ: https://www.polarismarketresearch.com/industry-analysis/impregnating-resins-market/request-for-sample
๐๐ก๐ ๐๐ฆ๐ฉ๐ซ๐๐ ๐ง๐๐ญ๐ข๐ง๐ ๐๐๐ฌ๐ข๐ง๐ฌ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐
โข ๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐:โฆ
More Releases for Geriatric
Soaring Geriatric Demographic & Sophisticated Technology Buttress Geriatric Medi โฆ
Governmentsโ relentless pitch for all-round assistance for geriatric people along with technological advancements aimed at ameliorating medical assistance has underpinned the geriatric medicines market. One of the insurance programs in the United States named as the Federal Long Term Care Insurance Program has aptly incorporated near-to-full medical cost of the Americans. Factors such as longer life-expectancy, aging demographic, swelled awareness and adoption of sophisticated therapeutics are prophesized to propel theโฆ
Cataract Market Geriatric & Future Scenario 2025
Global Cataract Market: Snapshot
The incrementing demand in the global cataract market is a reflection of growing geriatric population, as people aged over 60 years frequently develop conditions wherein eyes have reduced elasticity and in turn affects the normal functioning. The market for cataract is also expected to gain from awareness programs such as VISION 2020, launched by the WHO and the International Agency for the Prevention of Blindness.
Request Sample Copyโฆ
Global Geriatric Drugs and Disease Management Market: High Incidence of Chronic โฆ
Researchmoz added Most up-to-date research on "Global Geriatric Drugs and Disease Management Market: High Incidence of Chronic Ailments among Geriatric Population Crea" to its huge collection of research reports.
Geriatric medicine refers to a branch of medicine dealing with the diagnosis, treatment and prevention of diseases in the elderly population. Increasing demand for geriatric care medication and services is attributed to increasing needs of the elderly population. The geriatric population suffersโฆ
Geriatric Medicines Market Analysis & Trends 2023
The global market for geriatric medicines stood at US$ 504.7 bn in 2014 and is projected to expand at a CAGR of 7.3 % during 2015โ2023. Rising at this pace, the opportunities in the market is anticipated to reach US$ 948.0 bn by the end of 2023.
Governmentsโ Push for Quality Geriatric Care Bodes Well for Market
The global geriatric medicines market is primarily driven the general rise in the elderly populationsโฆ
Consistent Rise in Geriatric Population is Expected to Stimulate the Growth of G โฆ
Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions.
Complementary and alternative medicines include products such as dietary medicineโฆ
Consistent Rise in Geriatric Population is Expected to Stimulate Geriatric Compl โฆ
Geriatric Complementary and Alternative Medicines (CAM) Market: Overview
Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions.
Browse to unlockโฆ
